The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing entitled, ``Opioid Policy Steering Committee: Prescribing Intervention--Exploring a Strategy for Implementation.'' The purpose of the public hearing is to receive stakeholder input on how FDA might, under its Risk Evaluation and Mitigation Strategy (REMS) authority, improve the safe use of opioid analgesics by curbing overprescribing to decrease the occurrence of new addictions and limit misuse and abuse of opioid analgesics.
Document
Opioid Policy Steering Committee: Prescribing Intervention-Exploring a Strategy for Implementation; Public Hearing; Request for Comments
The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing entitled, ``Opioid Policy Steering Committee: Prescribing Intervention--Exploring a Stra...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 58572
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Opioid Policy Steering Committee: Prescribing Intervention-Exploring a Strategy for Implementation; Public Hearing; Request for Comments,” thefederalregister.org (December 13, 2017), https://thefederalregister.org/documents/2017-26785/opioid-policy-steering-committee-prescribing-intervention-exploring-a-strategy-for-implementation-public-hearing-request.